TITLE

The uphill battle facing antiobesity drugs

AUTHOR(S)
Daubresse, M; Alexander, G C
PUB. DATE
March 2015
SOURCE
International Journal of Obesity;Mar2015, Vol. 39 Issue 3, p377
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The authors reflect on the limited adoption of antibobesity drugs in clinical practice in the U.S. despite their association with short-term weight loss. They cite several antiobesity drugs that were withdrawn from the market due to the occurrence of adverse effects including sibutramine and orlistat. They also examine the position of the Food and Drug Administration on antiobesity drugs and obesity treatment.
ACCESSION #
101461456

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics